Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
14,340
+1,220 (9.30%)
At close: Feb 13, 2026
316.86% (1Y)
| Market Cap | 396.90B +301.1% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 237.66 |
| Forward PE | n/a |
| Dividend | 30.00 (0.21%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 19,674,170 |
| Average Volume | 4,766,671 |
| Open | 13,530 |
| Previous Close | 13,120 |
| Day's Range | 13,200 - 15,960 |
| 52-Week Range | 2,995 - 15,960 |
| Beta | 0.82 |
| RSI | 68.10 |
| Earnings Date | n/a |